Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02987569 · ClinicalTrials.gov registry record · NA
Teen and Young Adult Connections for Support From Multidisciplinary Professionals & Peers
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT02987569: Completed NA study, sponsored by University of Kansas Medical Center.
NCT02987569 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02987569, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
12 month study testing mobile delivery of health information and connections to professionals and peers to improve health of teen/young adult HPN users.
Primary Outcome
Physical and mental health status from each person's perspective. 7-Item Likert
Interventions
- BEHAVIORAL mConnect plus mobile connections to multidisciplinary professionals & peers
- BEHAVIORAL iPad use plus one mobile connections to multidisciplinary professionals & peers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2016-07 |
| Est. Completion | 2020-06 |
| Phase | NA |
What the finished NCT02987569 record still lists
NCT02987569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which mConnect plus mobile connections to multidisciplinary professionals & peers is the first listed.
NCT02987569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02987569 about?
NCT02987569 is a clinical study titled "Teen and Young Adult Connections for Support From Multidisciplinary Professionals & Peers". 12 month study testing mobile delivery of health information and connections to professionals and peers to improve health of teen/young adult HPN users.
What is the current status of trial NCT02987569?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2016-07. Estimated completion is 2020-06.
What interventions are being tested in trial NCT02987569?
The interventions under investigation include: mConnect plus mobile connections to multidisciplinary professionals & peers (BEHAVIORAL), iPad use plus one mobile connections to multidisciplinary professionals & peers (BEHAVIORAL).
Who is sponsoring clinical trial NCT02987569?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02987569's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia